Health Care: Drugs

Regeneron Pharmaceuticals Inc. (REGN: NASDAQ)

$263.64 -3.33 | -1.25%
05/20/13 - 04:00 PM ET
Company Income Statement
Dec 2012 Dec 2011 Dec 2010 Dec 2009
Sales 1.38B 445.82M 459.07M 379.27M
Cost of Sales 47.52M 4.22M 2.09M -12.56M
Gross Operating Profit 1.33B 441.61M 456.98M 391.83M
Selling, General, and Administrative Expenses 210.76M 117.26M 65.20M 52.92M
Research & Development 625.55M 529.51M 489.25M 398.76M
Operating Income before D & A (EBITDA) 494.65M -205.16M -97.47M -59.86M
Depreciation & Amortization 36.94M 31.08M 19.69M 14.25M
Interest Income 0.00 0.00 0.00 0.00
Other Income - Net 2.01M 3.55M 2.12M 4.49M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) 459.72M -232.69M -115.04M -69.62M
Interest Expense 45.30M 21.28M 9.12M 2.34M
Pre-Tax Income 414.42M -253.97M -124.16M -71.95M
Income Taxes -335.85M -1.13M 0.00 -4.12M
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations 750.27M -221.76M -104.47M -67.83M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 750.27M -221.76M -104.47M -67.83M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 750.27M -221.76M -104.47M -67.83M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)		 750.27M -221.76M -104.47M -67.83M
Preferred Dividends
Net Income Available To Common 750.27M -221.76M -104.47M -67.83M
Basic EPS from Continuing Ops. 7.92 -2.45 -1.26 -0.85
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 7.92 -2.45 -1.26 -0.85
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 7.92 -2.45 -1.26 -0.85
Basic Normalized Net Income/Share 7.92 -2.45 -1.26 -0.85
EPS fr Continuing Ops. 6.75 -2.45 -1.26 -0.85
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 6.75 -2.45 -1.26 -0.85
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 6.75 -2.45 -1.26 -0.85
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)		 6.75 -2.45 -1.26 -0.85
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with REGN

View All

Latest REGN Headlines from TheStreet

More Financial News for REGN

Press Releases for REGN

See All Press Releases

Partner Headlines for REGN

brokerage partners
watch thestreet tv
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter